Acerus Pharmaceuticals Co. (TSE:ASP) traded up 25% during mid-day trading on Wednesday . The stock traded as high as C$0.10 and last traded at C$0.10, 342,300 shares were traded during trading. An increase of 226% from the average session volume of 105,075 shares. The stock had previously closed at C$0.08.
The company has a market cap of $20.90 million and a PE ratio of -1.64. The company has a debt-to-equity ratio of 105.08, a quick ratio of 0.40 and a current ratio of 0.74. The firm’s 50 day moving average is C$0.09 and its 200-day moving average is C$0.12.
Acerus Pharmaceuticals Company Profile (TSE:ASP)
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.
Read More: Penny Stocks, Risk and Reward Factors
Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.